Pulse Biosciences, Inc. (PLSE) Analyst Estimates Annual - Discounting Cash Flows
PLSE
Pulse Biosciences, Inc.
PLSE (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2022
12-30
2021
12-30
Number of Analysts 1 1 1 1 1 1 1 1
Estimated Revenue
Low 93.8 41 11 3.38 0.168 0.8 0.709 1.45
Average 93.8 41 11 3.38 0.168 0.8 0.709 1.45
High 93.8 41 11 3.38 0.168 0.8 0.709 1.45
Estimated EBITDA
Low 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
Average 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
High 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
Estimated EBIT
Low 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
Average 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
High 18.76 8.2 2.2 0.675 0.034 0.16 0.142 0.289
Estimated Net Income
Low -18.1 -46.13 -50.22 -77.38 -59.86 -55.48 -102.2 -132.6
Average -18.1 -46.13 -50.22 -77.38 -59.86 -55.48 -102.2 -132.6
High -18.1 -46.13 -50.22 -77.38 -59.86 -55.48 -102.2 -132.6
Estimated SGA Expenses
Low 1,200 524.5 140.7 43.17 2.15 10.23 9.07 18.5
Average 1,200 524.5 140.7 43.17 2.15 10.23 9.07 18.5
High 1,200 524.5 140.7 43.17 2.15 10.23 9.07 18.5
Estimated EPS
Low -0.31 -0.79 -0.86 -1.32 -1.02 -0.95 -1.75 -2.27
Average -0.31 -0.79 -0.86 -1.32 -1.02 -0.95 -1.75 -2.27
High -0.31 -0.79 -0.86 -1.32 -1.02 -0.95 -1.75 -2.27
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program